1. Home
  2. IVVD vs SHMD Comparison

IVVD vs SHMD Comparison

Compare IVVD & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • SHMD
  • Stock Information
  • Founded
  • IVVD 2020
  • SHMD 1864
  • Country
  • IVVD United States
  • SHMD Germany
  • Employees
  • IVVD N/A
  • SHMD N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • SHMD
  • Sector
  • IVVD Health Care
  • SHMD
  • Exchange
  • IVVD Nasdaq
  • SHMD Nasdaq
  • Market Cap
  • IVVD 123.8M
  • SHMD 135.6M
  • IPO Year
  • IVVD 2021
  • SHMD N/A
  • Fundamental
  • Price
  • IVVD $0.65
  • SHMD $3.36
  • Analyst Decision
  • IVVD Strong Buy
  • SHMD
  • Analyst Count
  • IVVD 3
  • SHMD 0
  • Target Price
  • IVVD $7.52
  • SHMD N/A
  • AVG Volume (30 Days)
  • IVVD 1.8M
  • SHMD 26.6K
  • Earning Date
  • IVVD 05-15-2025
  • SHMD 02-25-2025
  • Dividend Yield
  • IVVD N/A
  • SHMD N/A
  • EPS Growth
  • IVVD N/A
  • SHMD 1309.32
  • EPS
  • IVVD N/A
  • SHMD 1.07
  • Revenue
  • IVVD $25,384,000.00
  • SHMD $99,752,404.00
  • Revenue This Year
  • IVVD $606.63
  • SHMD N/A
  • Revenue Next Year
  • IVVD $83.30
  • SHMD N/A
  • P/E Ratio
  • IVVD N/A
  • SHMD $3.08
  • Revenue Growth
  • IVVD N/A
  • SHMD N/A
  • 52 Week Low
  • IVVD $0.36
  • SHMD $1.86
  • 52 Week High
  • IVVD $2.74
  • SHMD $5.45
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 52.71
  • SHMD N/A
  • Support Level
  • IVVD $0.52
  • SHMD N/A
  • Resistance Level
  • IVVD $0.80
  • SHMD N/A
  • Average True Range (ATR)
  • IVVD 0.08
  • SHMD 0.00
  • MACD
  • IVVD 0.01
  • SHMD 0.00
  • Stochastic Oscillator
  • IVVD 50.70
  • SHMD 0.00

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: